UK markets closed

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHEZF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.72060.0000 (0.00%)
At close: 09:30AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
5,517,802
5,445,572
7,159,411
6,365,177
5,332,075
Cost of revenue
3,697,827
3,645,269
4,825,010
4,332,138
3,244,269
Gross profit
1,819,975
1,800,303
2,334,401
2,033,039
2,087,806
Operating expenses
Research development
191,213
182,433
252,142
221,099
160,008
Selling general and administrative
563,261
662,060
664,996
572,835
559,667
Total operating expenses
1,072,479
1,160,308
1,211,852
1,068,874
960,975
Operating income or loss
747,496
639,995
1,122,549
964,165
1,126,831
Interest expense
206,846
223,219
235,242
201,631
247,718
Income before tax
-824,686
-928,334
829,851
222,263
1,327,836
Income tax expense
-111,176
-126,175
114,816
-11,120
306,204
Income from continuing operations
-713,510
-802,159
715,035
233,383
1,021,632
Net income
-694,758
-783,258
727,426
240,788
1,024,210
Net income available to common shareholders
-694,758
-783,258
727,426
240,788
1,024,210
Basic EPS
0.15
-0.53
0.50
0.16
0.76
Diluted EPS
0.15
-0.53
0.50
0.16
0.76
Basic average shares
1,466,994
1,467,325
1,468,064
1,467,322
1,353,343
Diluted average shares
1,466,994
1,467,325
1,468,064
1,467,322
1,353,343